India’s Contract Manufacturing: Prospects And Pains
This article was originally published in PharmAsia News
Is the general uptrend in India's contract manufacturing segment sustainable, despite some sentiment-dampening run-ins with regulators over compliance concerns?
You may also be interested in...
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
Wockhardt has received approvals in India for two novel broad spectrum antibiotics with "advantageous" safety features over older MRSA drugs and the firm hopes to take them to other emerging markets as well, with China on the radar.